NSEDisclosure under SEBI Takeover Regulations14 Jul 2026 · 14 Jul 2026, 02:15 pm

Disclosure under SEBI Takeover Regulations

Unichem Laboratories Limited · UNICHEMLAB

✦ AI SummaryRegulatory

Unichem Laboratories Limited's promoters, IPCA Laboratories Limited, submitted a declaration under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, stating they have not made any encumbrance on the equity shares held in Unichem Laboratories Limited for the FY ended 31st March, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

IPCA Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Attachments (1)

📄

team_sandeshc_14072026121937_Unichem.pdf

pdf

Download →
View document text
A dose of life THRU E-MAIL April 2, 2026 The Secretary The National Stock Exchange of India Ltd. BSE Ltd. Exchange Plaza, 5,h Fir, Plot # C/1 Phiroze Jeejeebhoy Towers G Block, Bandra-Kurla Complex, 27th Floor, Dalai Street, Mumbai 400 023 Bandra (E), Mumbai 400 051 Email : corp.relations@bseindia.com E-mail : takeover@nse.co.in Dear Sir, Re: Declaration under Regulation 31 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, Unichem Laboratories Limited (Scrip code: BSE: 506690 and NSE: UNICHEMLAB) Pursuant to Regulation 31 (4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, we as promoters of Unichem Laboratories Limited (as listed in attached Annexure) hereby declare that we have not made any encumbrance, directly or indirectly, on the equity shares held by us in Unichem Laboratories Limited for the financial year ended 31st March, 2026. Kindly acknowledge the receipt. Thanking you, Yours faithfully, For and on behalf oflpca Laboratories Ltd. Harish Kamath Corporate Counsel & Company Secretary, ipca Laboratories Ltd. Cc: 1. Unichem Laboratories Limited Unichem Bhavan, Prabhat Estate, Off S.V.Road, Jogeshwari West MUMBAI -400102 E-mail id : pradeep.bhandari@unichemlabs.com 2. Audit Committee of Board of Directors of Unichem Laboratories Ltd. Ipca Laboratories Ltd. www.ipca.com 125, Kandivli Industrial Estate, CIS No. 328, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T:+91 22 6210 5000 F:+91 22 6210 5005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T: +91 22 6647 4444 E: ipca@ipca.com CIN: L24239MH1949PLC007837 A dose of life ANNEXURE - PROMOTERS AND PERSONS ACTING IN CONCERT WITHOUT No. Name(s) of the Promoters and Persons Acting in Concert (PAC) with the Promoters 1. Ipca Laboratories Limited I pea Laboratories Ltd. wvwv.ipca.com 125, Kandivli Industrial Estate, CTS No. 328, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T: +91 22 6210 5000 F: +91 22 6210 5005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T: +91 22 6647 4444 E: ipca@ipca.com CIN: L24239MH1949PLC007837